Reversible posterior leukoencephalopathy syndrome: A possible manifestation of Wegener's granulomatosis-mediated endothelial injury

Modern Rheumatology

Volumn 18, Issue 3, 2008, Pages 309-314

  Nishio, Minako ^a   Yoshioka, Katsunobu ^a   Yamagami, Keiko ^a   Morikawa, Takashi ^a   Konishi, Yoshio ^a   Hayashi, Noriko ^a   Himuro, Kimihide ^a   Imanishi, Masahito ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Reversible posterior leukoencephalopathy syndrome (RPLS); Vasculitis; Wegener's granulomatosis

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; C REACTIVE PROTEIN; CREATININE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NITROGEN; PREDNISOLONE; STEROID; UREA;

ABDOMINAL PAIN; ADOLESCENT; ANAPHYLACTOID PURPURA; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CELLULITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ENDOTHELIUM INJURY; ENTEROPATHY; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GRAND MAL SEIZURE; HEADACHE; HEMOPTYSIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; LEUKOENCEPHALOPATHY; MELENA; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD TEST; PATIENT TRANSPORT; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; PULMONARY VASCULITIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINALYSIS; WEGENER GRANULOMATOSIS;

ADOLESCENT; ENDOTHELIUM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PLASMA EXCHANGE; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PULSE THERAPY, DRUG; STEROIDS; WEGENER GRANULOMATOSIS;

EID: 46549088751     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-008-0052-1     Document Type: Article

References (31)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500.
2. Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: Evaluation with diffusion-tensor MR imaging. Radiology. 2001;219:756-65.
3. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000;69:467-72.
4. Foocharoen C, Tiamkao S, Srinakarin J, Chamadol N, Sawanyawisuth K. Reversible posterior leukoencephalopathy caused by azathioprine in systemic lupus erythematosus. J Med Assoc Thai. 2006;89:1029-32.
5. Arai M, Shigeno K, Wada M. A reversible posterior leukoencephalopathy syndrome in a patient with classical polyarteritis nodosa. Rinsho Shinkeigaku. 1997;37:64-6.
6. Primavera A, Audenino D, Mavilio N, Cocito L. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis. 2001;60:534-7.
7. Kawano H, Kimura E, Ishizaki M, Nishida Y, Matsumoto N, Yamashita T et al. Reversible posterior leukoencephalopathy syndrome in two patients with microscopic polyarteritis nodosa. Rinsho Shinkeigaku. 2002;42:949-53.
8. Yong PF, Hamour SM, Burns A. Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant. 2003;18:2660-2.
9. Ohta T, Sakano T, Shiotsu M, Furue T, Ohtani H, Kinoshita Y et al. Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol. 2004;19:442-4.
10. Mavragani CP, Vlachoyiannopoulous PG, Kosmas N, Boletis I, Tzioufas AG, Voulgarelis M. A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology (Oxford). 2004;43:1450-1.
11. Thaipisuttikul I, Phanthumchinda K. Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol. 2005;252:230-1.
12. Shin KC, Choi HJ, Bae YD, Lee JC, Lee EB, Song YW. Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. J Clin Rheumatol. 2005;11:164-6.
13. Tajima Y, Matsumoto A. Reversible posterior leukoencephalopathy syndrome in p-ANCA-associated vasculitis. Inter Med. 2006;45(20):1169-71.
14. Magnano MD, Bush TM, Herrera I, Altman RD. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2006;35:396-402.
15. Min L, Zwerling J, Ocava LC, Chen IH, Putterman C. Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum. 2006;35:388-95.
16. Kur JK, Esdaile JM. Posterior reversible encephalopathy syndrome - an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol. 2006;33:2178-83.
17. Ishimori ML, Pressman BD, Wallace DJ, Weisman MH. Posterior reversible encephalopathy syndrome: Another manifestation of CNS SLE? Lupus. 2007;16:436-43.
18. Cassano G, Gongora V, Zunino A, Roverano S, Paira S. Reversible posterior leukoencephalopathy in systemic lupus erythematosus with thrombotic thrombocytopenic purpura. J Clin Rheumatol. 2007;13:55-7.
19. Lateef A, Lim AY. Case reports of transient loss of vision and systemic lupus erythematosus. Ann Acad Med Singapore. 2007;36:146-9.
20. Preston GA, Yang JJ, Xiao H, Falk RJ. Understanding the pathogenesis of ANCA: Where are we today? Cleve Clin J Med. 2002;69 Suppl 2:SII51-4.
21. Edwards MJ, Walker R, Vinnicombe S, Barlow C, MacCallum P, Foran JM. Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol. 2001;12:1327-9.
22. Lewis GD, Campbell WB, Johnson AR. Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology. 1986;119:62-9.
23. Ay H, Buonanno FS, Schaefer PW, Le DA, Wang B, Gonzalez RG et al. Posterior leukoencephalopathy without severe hypertension: Utility of diffusion-weighted MRI. Neurology. 1998;51:1369-76.
24. Sugimoto T, Deji N, Kume S, Osawa N, Sakaguchi M, Isshiki K et al. Pulmonary-renal syndrome, diffuse pulmonary hemorrhage and glomerulonephritis, associated with Wegener's granulomatosis effectively treated with early plasma exchange therapy. Intern Med. 2007;46:49-53.
25. Akca T, Colak T, Caglikulekci M, Ocal K, Aydin S. Intestinal perforation in Wegener's granulomatosis: A case report. Ulus Travma Derg. 2005;11:348-51.
26. Storesund B, Gran JT, Koldingsnes W. Severe intestinal involvement in Wegener's granulomatosis: Report of two cases and review of the literature. Br J Rheumatol. 1998;37:387-90.
27. Geraghty J, Mackay IR, Smith DC. Intestinal perforation in Wegener's granulomatosis. Gut. 1986;27:450-1.
28. Tokuda M, Kurata N, Daikuhara H, Akisawa M, Onishi I, Asano T et al. Small intestinal perforation in Wegener's granulomatosis. J Rheumatol. 1989;16:547-9.
29. Kitamura N, Matsukawa Y, Takei M, Mitamura K, Nishinarita S, Sawada S, Horie T. Wegener's glanulomatosis complicated with intestinal ulceration. Mod Rheumatol. 2004;14:480-4.
30. Walton EW. Giant cell granuloma of the repiratory tract (Wegener's granulomatosis). Br Med J. 1958;2:265-70.
31. Hoffman GS, Kerr GS, Leavitt RY, Hallahan GW, Lebovics RS, Travis WD et al. Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med. 1992;116:488-98.